ICD-10-CM Billable Code

Z12.31

Encounter for screening mammogram for malignant neoplasm of breast

Clinical Classification Guidelines

Excludes Type 1

  • inconclusive mammogram (R92.2)

Medical Intelligence & Overview

A screening mammogram is a specialized X-ray imaging test designed to detect early signs of breast cancer in women who have no symptoms. The primary goal is to identify any abnormal changes or growths in the breast tissue at an early stage, increasing the chances for successful treatment. This examination is a crucial component of preventive health care for women, especially those over the age of 40 or with increased risk factors. The ICD-10 code Z12.31 signifies an encounter specifically for a screening mammogram aimed at detecting malignant neoplasms in the breast before symptoms appear.

Causes & Symptoms

Clinical Causes: Routine screening as part of health maintenance for women over age 40 Family history of breast cancer, increasing risk factors Previous history of benign breast disease requiring monitoring Exposure to radiation or environmental carcinogens Hormonal factors and lifestyle choices influencing breast cancer risk

Key Symptoms: No symptoms—most screening mammograms are performed routinely Potential incidental findings indicating abnormalities If cancer develops, symptoms may include a lump, unusual skin changes, or nipple abnormalities, but these are typically not present during screening

Diagnostic & Treatment

Diagnosis Path: Diagnosis begins with a screening mammogram, which is a low-dose X-ray of the breast tissue. The radiologist evaluates the images for any abnormal areas that could indicate malignancy. If abnormalities are detected, additional tests such as diagnostic mammograms, ultrasound, or biopsy may be necessary to confirm whether cancer is present. The process often involves measuring breast tissue density and spotting calcifications or masses that could suggest cancerous growths.

Treatment Protocols: Since Z12.31 is related to screening and not active cancer diagnosis, treatment is not administered directly based on the screening itself. Instead, the results of the screening influence future management, which may include more frequent monitoring, diagnostic procedures, or treatment if cancer is confirmed. Early detection through screening typically leads to a wider array of treatment options and better outcomes for patients. If an abnormality is found, treatment options might encompass surgery, radiation therapy, chemotherapy, hormonal therapy, or targeted treatments, depending on the type and stage of the cancer.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z12.31 a billable ICD-10 code?
Yes, Z12.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z12.31?
Clinical documentation must specify the nature of Encounter for screening mammogram for malignant neoplasm of breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

neoplasm screening malignant mammogram encounter